Search research articles
Contact Us
Filters
Showing results (21-30 of 27) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 27 results.
Science Immunology
|
April 12, 2020
Gut-resident CX3CR1<sup>hi</sup> macrophages induce tertiary lymphoid structures and IgA response in situ
Balázs Koscsó, Sravya Kurapati, Richard R Rodrigues, et al.
Nature Medicine
|
March 1, 2022
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A McCulloch, Diwakar Davar, Richard R Rodrigues, et al.
Science (New York, N.Y.)
|
February 5, 2021
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar, Amiran K Dzutsev, John A McCulloch, et al.
Science (New York, N.Y.)
|
April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunity
Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.
Cell
|
July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy
Catherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Cancer Cell
|
November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Science (New York, N.Y.)
|
December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 27) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 27 results.
Science Immunology
|
April 12, 2020
Gut-resident CX3CR1<sup>hi</sup> macrophages induce tertiary lymphoid structures and IgA response in situ
Balázs Koscsó, Sravya Kurapati, Richard R Rodrigues, et al.
Nature Medicine
|
March 1, 2022
Intestinal microbiota signatures of clinical response and immune-related adverse events in melanoma patients treated with anti-PD-1
John A McCulloch, Diwakar Davar, Richard R Rodrigues, et al.
Science (New York, N.Y.)
|
February 5, 2021
Fecal microbiota transplant overcomes resistance to anti-PD-1 therapy in melanoma patients
Diwakar Davar, Amiran K Dzutsev, John A McCulloch, et al.
Science (New York, N.Y.)
|
April 25, 2024
Vitamin D regulates microbiome-dependent cancer immunity
Evangelos Giampazolias, Mariana Pereira da Costa, Khiem C Lam, et al.
Cell
|
July 10, 2025
Exercise-induced microbiota metabolite enhances CD8 T cell antitumor immunity promoting immunotherapy efficacy
Catherine M Phelps, Nathaniel B Willis, Tingting Duan, et al.
Cancer Cell
|
November 1, 2024
Neoadjuvant vidutolimod and nivolumab in high-risk resectable melanoma: A prospective phase II trial
Diwakar Davar, Robert M Morrison, Amiran K Dzutsev, et al.
Science (New York, N.Y.)
|
December 23, 2021
Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response
Christine N Spencer, Jennifer L McQuade, Vancheswaran Gopalakrishnan, et al.
Page
of 3